menu close
www.moximed.com

Moximed Stock

Company Profile:

Moximed develops and distributes unicompartmental load absorber implants for active patients suffering from knee osteoarthritis (OA). The Company provides a joint preserving/unloading therapy - the Atlas Knee System, an implantable joint unloader.

Sign up for SecondMarket™ to view the market and buy or sell Moximed Stock
Buy + Sell

Moximed Funding

Sign up to gain insights into Moximed funding history, including the funding round, time period, and amount raised.

Sign Up to Unlock the Data
Date Financing Round Amount Price per share* Valuation*
Aug 07, 2024 Series D 62.71M
Price
Valuation
Mar 15, 2017 Series C 49.54M
Price
Valuation
May 07, 2015 Series B 13.26M
Price
Valuation
Apr 23, 2015 Series B 19.74M
Price
Valuation
Dec 05, 2011 Series A 2.57M
Price
Valuation
Aug 05, 2009 Series A 10.00M
Price
Valuation
Jun 09, 2008 Series A 2.29M
Price
Valuation
Apr 15, 2008 Series A 18.50M
Price
Valuation

*Access the PPS, Valuation details, and a wealth of other data by signing up. Source: Nasdaq Private Market Tape D™

Leverage Your Equity to Help Achieve More.

Moximed Management Team

  • Director

    Dave Amerson

  • CEO, President, Director

    Christopher Gleason

  • Director

    Shahzad Malik

  • Director

    Matt McAviney

  • Director

    Michael Wasserman

  • Director

    David Van Meter

  • Chief Financial Officer, Strategy Officer

    James Leech

  • Director

    Joshua Makower

Moximed Major Investors

  • Vertex Venture Holdings, Ltd.

  • Morgenthaler Ventures

  • Cormorant Asset Management

  • Advent Life Sciences

  • Frazier Healthcare Ventures

  • Warren Point Capital

  • Elevage Medical Technologies

  • Future Fund

  • Vertex Ventures

  • GBS Venture Partners Pty Ltd

  • Gilde Healthcare Partners BV

  • New Enterprise Associates Inc (NEA)

Learn More About Moximed Stock

Buy Moximed Stock
01

Moximed stock does not trade on public stock exchanges. Moximed stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Moximed stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.

Learn more about the secondary market for private company shares on the investors page.

Sell Moximed Stock
02

Moximed Stock does not trade on public stock exchanges. In order to sell Moximed shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.

Learn more about NPM services for selling privately held stock on the Employee Shareholders page.

Read more about how to sell private company stock on the private secondary market:

Moximed Stock Price
03

Moximed does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the Tape D™ database from Nasdaq Private Market, you can view Moximed share price and other valuable private market data.

Read more about secondary market private company stock prices:

Moximed Stock Ticker Symbol
04

There is no ticker symbol for Moximed stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.

Criteria to Sell Moximed Stock
05

Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Moximed stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.

Learn more about selling privately held stock on the Employee Shareholders page.

Read more about how to sell shares of a private company and eligibility for selling privately held stock:

Criteria to Buy or Invest in Moximed Stock
06

Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Moximed stock, you need to be an accredited entity or institutional investor.

Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.

Moximed Stock Settlement
07

Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.

To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.

Moximed IPO
08

Moximed is a private company and has not had an IPO. There is currently no Moximed IPO price. Get started to begin exploring the Nasdaq Private Market Tape D™ database and gain access to actionable data related to Moximed IPO.

Learn more about Tape D™ private company stock data for institutional investors on the on the Tape D™ Product Page.

Sign up for SecondMarket™ to view the market and buy or sell Moximed Stock
Buy + Sell

*All trademarks are the property of their respective owner(s). Unless expressly stated otherwise, companies listed on this site are not sponsoring, endorsing, or otherwise affiliated with, Nasdaq Private Market, LLC, and none of the statements on this website should be attributed to a listed company.

Other Companies

Cerebral

Telemedicine mental health startup, providing evidence-based therapeutic techniques and medication management.

Hinge Health-Logo

Hinge Health

Digital clinic for back, joint, and muscle pain.

Somatus-Logo

Somatus

integrated care for patients with or at risk of developing kidney disease.

Cityblock Health-Logo

Cityblock Health

Tech-driven care provider for communities with complex needs.

Lyra Healthcare-Logo

Lyra

Digital health startup using technology to connect companies and employees to mental health providers.

Cedar Inc-Logo

Cedar

The tech platform uses modern intelligence to improve healthcare financial experiences for everyone.

Swordhealth-Logo

Sword Health

Virtual musculoskeletal care provider.

Heartflow Inc-Logo

Heartflow

Develops non-invasive solutions to assess significant coronary artery disease.

Komodo Health

Provides a predictive analytics platform that leverages real-time data to improve healthcare decision-making.

Source: Nasdaq Private Market Tape D™